Stock Information

• CG Oncology Reports Positive First Results from CORE‑008 Cohort CX Phase 2 Trial Evaluating Intravesical Combination Therapy in High-Risk BCG-Exposed and BCG-Unresponsive Patients
  Fri, May 15, 2026 12:00 PM
• CG Oncology Reports First Results From CORE‑008 Cohort CX Phase 2 Trial
  Fri, May 15, 2026 8:04 AM
• CG Oncology BLA Filing on Track as Key Bladder Cancer Data Nears
  Fri, May 15, 2026 7:07 AM
• Truist Securities Reiterates Buy on CG Oncology, Raises Price Target to $82
  Thu, May 14, 2026 10:42 AM
• CG Oncology, Inc. (CGON) Presents at Bank of America Global Healthcare Conference 2026 Transcript
  Tue, May 12, 2026 4:21 PM
• Transcript : CG Oncology, Inc. Presents at Bank of America Global Healthcare Conference 2026, May-12-2026 10
  Tue, May 12, 2026 2:50 PM
• CG Oncology’s Presence at American Urological Association (AUA) Annual Meeting Underscores its Strong Commitment to NMIBC
  Mon, May 11, 2026 8:15 PM
• JP Morgan Maintains Overweight on CG Oncology, Raises Price Target to $96
  Mon, May 11, 2026 3:18 PM
• CG Oncology Analysts Boost Their Forecasts Following Q1 Earnings
  Mon, May 11, 2026 12:40 PM
• RBC Capital Maintains Outperform on CG Oncology, Raises Price Target to $81
  Mon, May 11, 2026 10:57 AM

Financial data not available